Literature DB >> 11552990

E1A3 as a unique, naturally occurring BCR-ABL transcript in an indolent case of chronic myeloid leukaemia.

J Roman1, A Jimenez, M Barrios, J A Castillejo, J Maldonado, A Torres.   

Abstract

A woman with Ph-positive chronic myeloid leukaemia (CML) with an atypical e1a3 BCR-ABL hybrid gene is described. To our knowledge, this is the first report of this transcript type as a unique naturally occurring BCR-ABL fusion in a CML patient. This case was characterized by a low leucocyte count and a very indolent course without treatment. Because the deletion of ABL exon 2 sequences results in deletion of an essential part of the ABL SH3 domain, our case suggests that this ABL SH3 domain is not absolutely necessary for efficient induction of a myeloproliferative disease in the context of BCR-ABL/p190.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11552990     DOI: 10.1046/j.1365-2141.2001.02971.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Two cases of acute lymphoblastic leukemia with an e1a3 BCR-ABL1 fusion transcript.

Authors:  Sang-Yong Shin; Jin-Hee Cho; Hee-Jin Kim; Jun-Ho Jang; Seung-Tae Lee; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

2.  Aleukemic Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia with E1A3 BCR-ABL1 Fusion Transcript.

Authors:  Naoki Miyashita; Masahiro Onozawa; Keito Suto; Shinichi Fujisawa; Nanase Okazaki; Daisuke Hidaka; Hiroyuki Ohigashi; Atsushi Yasumoto; Junichi Sugita; Daigo Hashimoto; Yoshihiro Matsuno; Takanori Teshima
Journal:  Intern Med       Date:  2021-09-11       Impact factor: 1.282

Review 3.  A variant transcript, e1a3, of the minor BCR-ABL fusion gene in acute lymphoblastic leukemia: case report and review of the literature.

Authors:  Shinya Fujisawa; Satoki Nakamura; Kensuke Naito; Masahide Kobayashi; Kazunori Ohnishi
Journal:  Int J Hematol       Date:  2008-02-06       Impact factor: 2.490

4.  Optimal Molecular Methods in Detecting p190 (BCR-ABL) Fusion Variants in Hematologic Malignancies: A Case Report and Review of the Literature.

Authors:  Rebecca J Sonu; Brian A Jonas; Denis M Dwyre; Jeffrey P Gregg; Hooman H Rashidi
Journal:  Case Rep Hematol       Date:  2015-04-08

5.  Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases.

Authors:  Bernardo López-Andrade; Francesca Sartori; Antonio Gutiérrez; Lucia García; Vanesa Cunill; María Antonia Durán; Antonia Sampol; Marta Bernués; Julio Iglesias; Rafael Ramos; Josep Lladó; María Sánchez; Juan Carlos Amat; Jordi Martínez-Serra
Journal:  Exp Hematol Oncol       Date:  2016-07-29

6.  Heterogeneity of BCR-ABL rearrangement in patients with chronic myeloid leukemia in Pakistan.

Authors:  Najia Tabassum; Mohammad Saboor; Rubina Ghani; Moinuddin Moinuddin
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

7.  Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis.

Authors:  Jordi Martinez-Serra; Raquel Del Campo; Antonio Gutierrez; Jose Luis Antich; Magdalena Ginard; Maria A Durán; Leyre Bento; Teresa Ros; Juan C Amat; Carmen Vidal; Julio F Iglesias; Izabela Orlinska; Joan Besalduch
Journal:  Biomark Res       Date:  2014-08-14

8.  Chronic Myeloid Leukemia with b3a3 (e14a3) Fusion: A Rare BCR/ABL Rearrangement Presenting with Thrombocytosis - Does MTHFR Polymorphism Matter.

Authors:  Mohammad Muhsin Chisti; Daniel Steven Sanders
Journal:  Case Rep Oncol       Date:  2018-07-16

Review 9.  Prognostic Significance of Transcript-Type BCR - ABL1 in Chronic Myeloid Leukemia.

Authors:  Matteo Molica; Elisabetta Abruzzese; Massimo Breccia
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-09-01       Impact factor: 2.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.